Pancreas-Targeted GLP-1Gene Therapy Enhances β-Cell Function and Reduces Cellular Stress in Preclinical Type 2 Diabetes Models

Rejuva

June 10, 2026 by

May 15, 2026 by

May 6, 2026 by

May 6, 2026 by

June 22, 2025 by

May 17, 2025 by

May 5, 2025 by

December 12, 2024 by

November 4, 2024 by

Our Focus
- Obesity
- Type 2 Diabetes
Our Platforms
- Revita
- Rejuva
Our Science
- Clinical Studies
- Presentations & Publications
Our Company
- Culture
- Our Team
- Careers
Our News
- Media Kit
Investors